Prenetics Group has partnered with ACON Bio to launch the Flowflex SARS-CoV-2 Antigen Rapid Test Kit in Hong Kong.

FlowFlex is well-equipped with the latest patented technology and provides results in just 15 minutes with 98.8% accuracy.

Led by Copenhagen University Hospital, Denmark, studies have revealed that FlowFlex achieved 94% sensitivity and 100% specificity, outperforming all test kits, including from Roche and Abbott.

Flowflex is authorized by FDA under an EUA and has the CE Mark for self-testing, is available in more than 100 countries around the world and is used by the National Health Service (NHS) in the United Kingdom as well as by governments and medical associations in the United States, Singapore, Australia, and many more. The test is suitable for use in individuals with and without COVID-19 symptoms, and for children as young as two years old.